BRAF: from gene to cancer therapy

preview_player
Показать описание
Wellcome Trust Sanger Institute scientist Ultan McDermott tells the story of BRAF. This gene was discovered to be mutated in 40% of malignant melanoma by researchers who sequenced cancer genomes. As a result drugs have been developed to target a particular mutation in BRAF prolonging the life of people with this form of cancer.

Рекомендации по теме
visit shbcf.ru